James Chappell

Since becoming president and CEO of SCbio in 2021, James Chappell has built a statewide coalition of partners united in elevating South Carolina as a premier hub for scientific research, advanced biomanufacturing, and patient care. South Carolina has become a magnet for CDMOs, digital health innovators and early-stage companies. SCbio is shaping policy, workforce development and investment strategies to fuel that momentum, helping the state build a ground-up playbook for life sciences growth. Chappell works directly with stakeholders and investors to position South Carolina as a destination for pharmaceutical operations. He forged a key alliance with MassBio to create SCbioDrive, which draws startups from around the world and reinforces the state’s emergence as a rising force in the national life sciences ecosystem.